Laurel Wealth Advisors (California)’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,851
Closed -$318K 655
2022
Q1
$318K Buy
4,851
+463
+11% +$30K 0.03% 565
2021
Q4
$305K Buy
+4,388
New +$319K 0.02% 616

Other funds holding ATRC

Laurel Wealth Advisors (California)'s ATRC Position: Q2 2022 in Review

Laurel Wealth Advisors (California) sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 4,851 shares — an estimated $318K sold.

Laurel Wealth Advisors (California) first reported a position in ATRC in Q4 2021 and held it in 2 quarters. The position peaked at $318K in Q1 2022. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

  • Laurel Wealth Advisors (California) reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 4,851 AtriCure shares in Q2 2022, an estimated $318K.
  • Laurel Wealth Advisors (California) first reported a position in AtriCure in Q4 2021 and held it in 2 quarters.
  • Laurel Wealth Advisors (California)'s AtriCure position peaked at $318K in Q1 2022.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.